Location History:
- St. Louis, MO (US) (1997 - 2020)
- Temple Terrace, FL (US) (2021 - 2023)
Company Filing History:
20 out of 36 
18 out of 1,586 
4 out of 1,933 
Years Active: 1997-2023
Areas of Expertise:
Title: The Innovator: Samuel A Wickline
Introduction
Samuel A Wickline, a prolific inventor based in St. Louis, MO (US), has made significant contributions to the field of medical nanotechnology. With an impressive portfolio of 42 patents, Wickline is known for his groundbreaking work in developing innovative nanoparticles for medical applications.
Latest Patents
Some of Wickline's latest patents include "Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis", focusing on combating a serious condition, and "Peptide-polynucleotide-hyaluronic acid nanoparticles and methods for polynucleotide transfection", which revolutionizes polynucleotide transfection methods.
Career Highlights
Throughout his career, Wickline has collaborated with renowned institutions such as Barnes Jewish Hospital and Washington University. His tireless dedication to medical research and innovative spirit have led to the development of cutting-edge technologies that have the potential to revolutionize healthcare practices worldwide.
Collaborations
Wickline has worked closely with esteemed professionals in the field, including coworkers Gregory M Lanza and Hua Pan. Together, they have synergized their expertise to push the boundaries of medical nanotechnology and pave the way for future advancements in the industry.
Conclusion
In conclusion, Samuel A Wickline stands as a testament to the power of innovation and perseverance in the field of medical research. His remarkable contributions have not only enhanced our understanding of nanoparticle technology but have also opened new possibilities for transformative treatments in healthcare. Samuel A Wickline's pioneering work continues to inspire and shape the future of medical innovation.